AN2 Therapeutics
ANTX
#9498
Rank
C$42.01 M
Marketcap
$1.41
Share price
0.00%
Change (1 day)
-93.60%
Change (1 year)

Revenue for AN2 Therapeutics (ANTX)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AN2 Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A